Joaquin Mateo

Joaquin Mateo: Functional RAD51-IF to detect HRR defects in Prostate Cancer

Joaquin Mateo, Physician-Scientist at Vall d’Hebron Institute of Oncology, shared an article by Sara Arce-Gallego, et al. on X:

“Our latest paper is out in Cell Reports Medicine – Functional RAD51-IF to detect HRR defects in Prostate Cancer – exploring correlations between HRR mutations, HRD scores, and RAD51-IF in mPC biopsies.”

Joaquin Mateo: Functional RAD51-IF to detect HRR defects in Prostate Cancer

Homologous recombination repair status in metastatic prostate cancer by next-generation sequencing and functional immunofluorescence.

Authors: Sara Arce-Gallego, et al.

Joaquin Mateo: Functional RAD51-IF to detect HRR defects in Prostate Cancer